scholarly article | Q13442814 |
P2093 | author name string | Marcin Dominiak | |
P433 | issue | 6 | |
P304 | page(s) | 705-6; discussion 707 | |
P577 | publication date | 2008-06-01 | |
P1433 | published in | Kardiologia Polska | Q2775982 |
P1476 | title | Commentary to the article: ONTARGET Investigators, Yusuf S, Teo KK, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-59 | |
P478 | volume | 66 |
Q26865691 | Antihypertensive treatment and renal protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system |
Q38223595 | Current therapeutic approaches to cardio-protection in hypertension |
Q28535089 | Polymorphism of ORM1 is associated with the pharmacokinetics of telmisartan |
Q37502956 | The fixed-dose combination of olmesartan/amlodipine was superior in central aortic blood pressure reduction compared with perindopril/amlodipine: a randomized, double-blind trial in patients with hypertension |
Q34094354 | The past, present and future of renin-angiotensin aldosterone system inhibition |
Q53600013 | [Antihypertensive drug therapy : Where do we stand?]. |